Hosted on MSN15d
UCSD begins trial with Nexalin’s Halo Clarity device for mTBI and PTSD
The University of California, San Diego (UCSD) has initiated a clinical trial to assess Nexalin Technology's Halo Clarity device for treating mild traumatic brain injury (mTBI) and post-traumatic ...
Nasdaq18d
Nexalin Technology, Inc. Launches Clinical Trial for HALO™ Clarity Device to Treat Mild Traumatic Brain Injury and PTSD at UCSD
Nexalin Technology announces the shipment of HALO™ Clarity devices to UCSD for a clinical trial on mTBI and PTSD treatment. Nexalin Technology, Inc. has announced that the University of ...